Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127461871 | 12746187 | 1 | I | 20160905 | 20160915 | 20160915 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01820 | WESTWARD | MCINTYRE I,VALDEZ J,LUCAS J. AN ACUTE FATALITY AND POST-MORTEM CONCENTRATION DISTRIBUTION REVEALS A LOW POTENTIAL FOR NAPROXEN REDISTRIBUTION. CANADIAN SOCIETY OF FORENSIC SCIENCE JOURNAL 2016;. | 51.00 | YR | M | Y | 87.17000 | KG | 20160915 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127461871 | 12746187 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Unknown | 76494 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127461871 | 12746187 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127461871 | 12746187 | HO |
| 127461871 | 12746187 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127461871 | 12746187 | Cardiac arrest | |
| 127461871 | 12746187 | Coma | |
| 127461871 | 12746187 | Completed suicide | |
| 127461871 | 12746187 | Overdose | |
| 127461871 | 12746187 | Pneumonia | |
| 127461871 | 12746187 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |